000110465914012317txt 20140221 000110465914012317hdrsgml 20140221 20140221165016 accession number 000110465914012317 conformed submission type sc 14d9a public document count 1 filed date 20140221 date change 20140221 subject company company data company conformed name accelrys inc central index key 0001002388 standard industrial classification servicesprepackaged software 7372 irs number 330557266 state incorporation de fiscal year end 0331 filing value form type sc 14d9a sec act 1934 act sec file number 00544599 film number 14634278 business address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 business phone 858 7995000 mail address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 former company former conformed name pharmacopeia inc date name change 19951018 filed by company data company conformed name accelrys inc central index key 0001002388 standard industrial classification servicesprepackaged software 7372 irs number 330557266 state incorporation de fiscal year end 0331 filing value form type sc 14d9a business address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 business phone 858 7995000 mail address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 former company former conformed name pharmacopeia inc date name change 19951018 sc 14d9a 1 a1456045sc14d9ahtm sc 14d9 security exchange commission washington dc 20549 schedule 14d9 rule 14d101 solicitationrecommendation statement section 14d4 security exchange act 1934 amendment no 3 accelrys inc name subject company accelrys inc name person filing statement common stock 00001 par value per share title class security 00430u103 cusip number class security max carnecchia chief executive officer accelrys inc 5005 wateridge vista drive san diego california 921211761 858 7995000 name address telephone number person authorized receive notice communication behalf person filing statement copy to carl r sanchez scott e oross paul hastings llp 4747 executive drive 12th floor san diego california 92121 858 4583000 check box filing relates solely preliminary communication made commencement tender offer amendment no 3 this “amendment no 3” schedule 14d9 amends supplement schedule 14d9 a amended supplemented time time “schedule 14d9” previously filed accelrys inc delaware corporation the “company” security exchange commission the “sec” february 13 2014 relating offer i dassault systèmes sa “dassault systèmes sa” french corporation limited liability ii dassault systemes america corp delaware corporation wholly owned indirect subsidiary dassault systèmes sa “parent” iii 3d acquisition corp delaware corporation wholly owned direct subsidiary parent “purchaser” purchase outstanding share company’s common stock par value 00001 per share such share hereinafter collectively referred “shares” price per share 1250 net seller cash without interest subject required withholding tax term subject condition set forth offer purchase dated february 13 2014 related letter transmittal copy attached tender offer statement schedule filed dassault systèmes sa parent purchaser sec february 13 2014 may amended supplemented time time capitalized term used otherwise defined amendment no 3 shall meaning ascribed schedule 14d9 except set forth below information set forth schedule 14d9 remains unchanged incorporated herein reference relevant item amendment no 3 item 8 additional information item 8 schedule 14d9 hereby amended supplemented inserting following new paragraph immediately second paragraph subsection entitled “regulatory approvals—united states” page 57 schedule 14d9 “the exonflorio amendment provides national security review and appropriate investigation cfius transaction foreign person entity acquires control u business cfius review covered transaction subject initial 30day review period may extended cfius additional 45day investigation period pursuant exonflorio amendment cfius delegated authority receive notice proposed transaction determine investigation warranted conduct investigation require mitigation measure submit recommendation president suspend prohibit completion transaction require divestiture completed transaction party party transaction may required to submit cfius voluntary notice transaction except limited circumstance apply case agreed party pursuant term merger agreement february 11 2014 party timely filed cfius joint voluntary notice cfius accepted review letter dated february 21 2014 letter cfius confirmed february 21 2014 first day initial 30day review period initial review conclude later march 24 2014 date cfius may terminate review transaction initiate additional 45day investigation 1 signature due inquiry best knowledge belief certify information set forth statement true complete correct accelrys inc by s jason gray jason gray senior vice president general counsel corporate secretary date february 21 2014 2000110465914012317txt 20140221 000110465914012317hdrsgml 20140221 20140221165016 accession number 000110465914012317 conformed submission type sc 14d9a public document count 1 filed date 20140221 date change 20140221 subject company company data company conformed name accelrys inc central index key 0001002388 standard industrial classification servicesprepackaged software 7372 irs number 330557266 state incorporation de fiscal year end 0331 filing value form type sc 14d9a sec act 1934 act sec file number 00544599 film number 14634278 business address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 business phone 858 7995000 mail address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 former company former conformed name pharmacopeia inc date name change 19951018 filed by company data company conformed name accelrys inc central index key 0001002388 standard industrial classification servicesprepackaged software 7372 irs number 330557266 state incorporation de fiscal year end 0331 filing value form type sc 14d9a business address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 business phone 858 7995000 mail address street 1 5005 wateridge vista circle city san diego state ca zip 921213752 former company former conformed name pharmacopeia inc date name change 19951018 sc 14d9a 1 a1456045sc14d9ahtm sc 14d9 security exchange commission washington dc 20549 schedule 14d9 rule 14d101 solicitationrecommendation statement section 14d4 security exchange act 1934 amendment no 3 accelrys inc name subject company accelrys inc name person filing statement common stock 00001 par value per share title class security 00430u103 cusip number class security max carnecchia chief executive officer accelrys inc 5005 wateridge vista drive san diego california 921211761 858 7995000 name address telephone number person authorized receive notice communication behalf person filing statement copy to carl r sanchez scott e oross paul hastings llp 4747 executive drive 12th floor san diego california 92121 858 4583000 check box filing relates solely preliminary communication made commencement tender offer amendment no 3 this “amendment no 3” schedule 14d9 amends supplement schedule 14d9 a amended supplemented time time “schedule 14d9” previously filed accelrys inc delaware corporation the “company” security exchange commission the “sec” february 13 2014 relating offer i dassault systèmes sa “dassault systèmes sa” french corporation limited liability ii dassault systemes america corp delaware corporation wholly owned indirect subsidiary dassault systèmes sa “parent” iii 3d acquisition corp delaware corporation wholly owned direct subsidiary parent “purchaser” purchase outstanding share company’s common stock par value 00001 per share such share hereinafter collectively referred “shares” price per share 1250 net seller cash without interest subject required withholding tax term subject condition set forth offer purchase dated february 13 2014 related letter transmittal copy attached tender offer statement schedule filed dassault systèmes sa parent purchaser sec february 13 2014 may amended supplemented time time capitalized term used otherwise defined amendment no 3 shall meaning ascribed schedule 14d9 except set forth below information set forth schedule 14d9 remains unchanged incorporated herein reference relevant item amendment no 3 item 8 additional information item 8 schedule 14d9 hereby amended supplemented inserting following new paragraph immediately second paragraph subsection entitled “regulatory approvals—united states” page 57 schedule 14d9 “the exonflorio amendment provides national security review and appropriate investigation cfius transaction foreign person entity acquires control u business cfius review covered transaction subject initial 30day review period may extended cfius additional 45day investigation period pursuant exonflorio amendment cfius delegated authority receive notice proposed transaction determine investigation warranted conduct investigation require mitigation measure submit recommendation president suspend prohibit completion transaction require divestiture completed transaction party party transaction may required to submit cfius voluntary notice transaction except limited circumstance apply case agreed party pursuant term merger agreement february 11 2014 party timely filed cfius joint voluntary notice cfius accepted review letter dated february 21 2014 letter cfius confirmed february 21 2014 first day initial 30day review period initial review conclude later march 24 2014 date cfius may terminate review transaction initiate additional 45day investigation 1 signature due inquiry best knowledge belief certify information set forth statement true complete correct accelrys inc by s jason gray jason gray senior vice president general counsel corporate secretary date february 21 2014 2